Literature DB >> 28865366

Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis.

Huihua Chen1, Haiyan Song2, Xiao Liu1, Jing Tian1, Wenzhu Tang1, Tongtong Cao2, Pei Zhao2, Chen Zhang1, Wei Guo1, Ming Xu3, Rong Lu4.   

Abstract

Buyanghuanwu Decoction (BHD), a traditional Chinese medicine recipe, is a representative prescription for the treatment of qi-deficiency and blood-stasis syndrome. In this study, the effect of BHD on pressure overload induced cardiac remodeling was investigated and possible mechanism underlying was explored. Rats were randomly divided into four groups: sham, transverse aorta constriction (TAC) with saline, TAC with telmisartan (TAC+Tel), and TAC with BHD (TAC+BHD) for 16 weeks (n=6∼8 in each group). Cardiac morphological and functional changes were evaluated by echocardiography and histological methods, the molecular alterations were detected by western blotting. Our results revealed that pressure overload prominently induced cardiac dysfunction, dilated and atrophied left ventricle, decreased cardiomyocyte cross sectional area, and fibrosis. However, BHD, similar to Tel, greatly reversed cardiac dysfunction, left ventricular dilation, and fibrosis, together with increased left ventricular wall thickness and size of cardiomyocyte. Furthermore, activated classical pro-fibrotic signaling of Tgf-β/Smads and MAPKs after TAC was dramatically suppressed by BHD or Tel treatment. Taken together, it was demonstrated in this study that BHD exerted a cardioprotective effect against pressure overload induced cardiac remodeling via inactivation of Tgf-β/Smads and MAPKs signaling triggered fibrosis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Buyanghuanwu Decoction; Cardiac remodeling; Fibrosis; Mitogen-activated protein kinases; Smads; Transformation growth factor-β

Mesh:

Substances:

Year:  2017        PMID: 28865366     DOI: 10.1016/j.biopha.2017.08.102

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  BuyangHuanwu Decoction attenuates cerebral vasospasm caused by subarachnoid hemorrhage in rats via PI3K/AKT/eNOS axis.

Authors:  Weiping Li; Ru Wang; Wei Huang; Yanfang Shen; Jumei Du; Ye Tian
Journal:  Open Life Sci       Date:  2022-07-13       Impact factor: 1.311

Review 2.  Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis.

Authors:  Chunzhen Ren; Kai Liu; Xinke Zhao; Huan Guo; Yali Luo; Juan Chang; Xiang Gao; Xinfang Lv; Xiaodong Zhi; Xue Wu; Hugang Jiang; Qilin Chen; Yingdong Li
Journal:  Front Pharmacol       Date:  2022-06-08       Impact factor: 5.988

3.  A Network Pharmacology Approach to Predict the Proangiogenesis Mechanism of Huangqi-Honghua Herb Pair after Cerebral Ischemia.

Authors:  Jinyi Cao; Lu Lei; Kai Wang; Jing Sun; Yi Qiao; Jialin Duan; Chao Zhao; Jia Cui; Zhijun Feng; Jing-Wen Wang; Aidong Wen; Zhifu Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-14       Impact factor: 2.629

4.  Clinical Prescription-Protein-Small Molecule-Disease Strategy (CPSD), A New Strategy for Chinese Medicine Development: A Case Study in Cardiovascular Diseases.

Authors:  Yong-Zhi Guo; Ying-Nan Jiang; Yi-Fang Li; Hiroshi Kurihara; Yi Dai; Rong-Rong He
Journal:  Front Pharmacol       Date:  2020-01-22       Impact factor: 5.810

5.  Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Buyang Huanwu Decoction in the Treatment of Ischemic Stroke.

Authors:  Qiang Gao; Danfeng Tian; Zhenyun Han; Jingfeng Lin; Ze Chang; Dandan Zhang; Dayong Ma
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-26       Impact factor: 2.629

Review 6.  Cellular and Molecular Mechanism of Traditional Chinese Medicine on Ventricular Remodeling.

Authors:  Yong-Chun Zhu; Bo Liang; Ning Gu
Journal:  Front Cardiovasc Med       Date:  2021-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.